FindTrial
Sign In

The relevant research about immunological mechanism and their regulatory mechanism in age-related macular degeneration

The relevant research about immunological mechanism and their regulatory mechanism in age-related macular degeneration

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CCC-12002408
Enrollment
Unknown
Registered
2012-08-08
Start date
2012-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related macular degeneration

Interventions

Healthy controls:None
Age-related macular degeneration:Nil

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Aged 55 to 95; 2. Age-related macular degeneration was diagnosed according to the internatianal diagnostic criteria; 3. All people in both groups voluntarily joined this study with informed consents.

Exclusion criteria

Exclusion criteria: 1. patients with other autoimmune and infectious diseases; 2. The suspected cases; 3. Pepole with blood phobia.

Design outcomes

Primary

MeasureTime frame
Cytokines;Complement component fragment and complement regulation;Related micro-RNA of AMD;—

Countries

China

Contacts

Public ContactPeizeng Yang
peizengycmu@126.com+86 023 89012851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026